Business Description
Standard Chemical & Pharmaceutical Co Ltd
SIC : 2836
ISIN : TW0001720001
Description
Standard Chemical & Pharmaceutical Co Ltd is a pharmaceutical company. Along with its subsidiaries, the firm is engaged in the pharmaceutical development, manufacturing, and sales of Active Pharmaceuticals Ingredients (API), health supplements, medical equipment, neoangelac plus milk powder, and adult supplements. It offers pharmaceutical products in healthcare segments including the circulatory system, digestive system, metabolism, anti-microbial, membrane drugs, and respiratory system. The company generates a majority of its revenue from Taiwan.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.14 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.39 | |||||
| Debt-to-EBITDA | 1.08 | |||||
| Interest Coverage | 46.76 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.75 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.1 | |||||
| 3-Year EBITDA Growth Rate | 27.7 | |||||
| 3-Year EPS without NRI Growth Rate | 30.8 | |||||
| 3-Year FCF Growth Rate | -60 | |||||
| 3-Year Book Growth Rate | 12 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.6 | |||||
| 9-Day RSI | 48.83 | |||||
| 14-Day RSI | 45.38 | |||||
| 6-1 Month Momentum % | 9.44 | |||||
| 12-1 Month Momentum % | -13.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.09 | |||||
| Quick Ratio | 1.49 | |||||
| Cash Ratio | 0.87 | |||||
| Days Inventory | 150.51 | |||||
| Days Sales Outstanding | 58.69 | |||||
| Days Payable | 23.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.96 | |||||
| Dividend Payout Ratio | 0.52 | |||||
| 3-Year Dividend Growth Rate | 18.6 | |||||
| Forward Dividend Yield % | 3.96 | |||||
| 5-Year Yield-on-Cost % | 8 | |||||
| 3-Year Average Share Buyback Ratio | 3.5 | |||||
| Shareholder Yield % | 5.05 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.61 | |||||
| Operating Margin % | 20.32 | |||||
| Net Margin % | 13.61 | |||||
| FCF Margin % | 8.05 | |||||
| ROE % | 17.91 | |||||
| ROA % | 7.67 | |||||
| ROIC % | 13.76 | |||||
| ROC (Joel Greenblatt) % | 26.53 | |||||
| ROCE % | 18.27 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.33 | |||||
| PE Ratio without NRI | 13.2 | |||||
| Shiller PE Ratio | 19.66 | |||||
| Price-to-Owner-Earnings | 25.7 | |||||
| PEG Ratio | 0.71 | |||||
| PS Ratio | 1.81 | |||||
| PB Ratio | 2.23 | |||||
| Price-to-Tangible-Book | 2.34 | |||||
| Price-to-Free-Cash-Flow | 22.59 | |||||
| Price-to-Operating-Cash-Flow | 9.64 | |||||
| EV-to-EBIT | 7.5 | |||||
| EV-to-EBITDA | 6.11 | |||||
| EV-to-Revenue | 1.76 | |||||
| EV-to-FCF | 21.92 | |||||
| Price-to-Projected-FCF | 1.08 | |||||
| Price-to-DCF (Earnings Based) | 0.85 | |||||
| Price-to-DCF (FCF Based) | 1.46 | |||||
| Price-to-Median-PS-Value | 1.1 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.57 | |||||
| Price-to-Graham-Number | 1.17 | |||||
| Earnings Yield (Greenblatt) % | 13.33 | |||||
| FCF Yield % | 4.43 | |||||
| Forward Rate of Return (Yacktman) % | 24.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Standard Chemical & Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 6,230.825 | ||
| EPS (TTM) (NT$) | 4.74 | ||
| Beta | -0.03 | ||
| Volatility % | 20.59 | ||
| 14-Day RSI | 45.38 | ||
| 14-Day ATR (NT$) | 0.845113 | ||
| 20-Day SMA (NT$) | 63.75 | ||
| 12-1 Month Momentum % | -13.25 | ||
| 52-Week Range (NT$) | 58.1 - 79.6 | ||
| Shares Outstanding (Mil) | 178.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Standard Chemical & Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Standard Chemical & Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Standard Chemical & Pharmaceutical Co Ltd Frequently Asked Questions
What is Standard Chemical & Pharmaceutical Co Ltd(TPE:1720)'s stock price today?
The current price of TPE:1720 is NT$63.20. The 52 week high of TPE:1720 is NT$79.60 and 52 week low is NT$58.10.
When is next earnings date of Standard Chemical & Pharmaceutical Co Ltd(TPE:1720)?
The next earnings date of Standard Chemical & Pharmaceutical Co Ltd(TPE:1720) is .
Does Standard Chemical & Pharmaceutical Co Ltd(TPE:1720) pay dividends? If so, how much?
The Dividend Yield %  of Standard Chemical & Pharmaceutical Co Ltd(TPE:1720) is 3.96% (As of Today), Highest Dividend Payout Ratio of Standard Chemical & Pharmaceutical Co Ltd(TPE:1720) was 1.2. The lowest was 0.26. And the median was 0.53. The  Forward Dividend Yield % of Standard Chemical & Pharmaceutical Co Ltd(TPE:1720) is 3.96%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers